U.S. markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real Time Price. Currency in USD
342.24+1.05 (+0.31%)
At close: 04:00PM EST
342.23 -0.01 (-0.00%)
After hours: 04:25PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close341.19
Bid330.74 x 1100
Ask344.80 x 1800
Day's Range338.30 - 342.27
52 Week Range224.15 - 415.73
Avg. Volume380,482
Market Cap25.322B
Beta (5Y Monthly)1.07
PE Ratio (TTM)46.06
EPS (TTM)7.43
Earnings DateFeb 14, 2024 - Feb 19, 2024
Forward Dividend & Yield0.80 (0.23%)
Ex-Dividend DateJan 30, 2024
1y Target Est390.43
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-24% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for WST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • West Pharmaceutical Services, I
    WST: Lowering target price to $361.00WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $361.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • PR Newswire

    West Announces First-Quarter 2024 Dividend

    West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2024 dividend of $0.20 per share. The dividend will be paid on February 7, 2024, to shareholders of record as of January 31, 2024.

  • Zacks

    West Pharmaceutical's (WST) New Launch to Expand Portfolio

    West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.

  • PR Newswire

    West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device

    West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device.